- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05404438
Mouth Breathing Habits Improvement Intervention
June 1, 2022 updated by: National Yang Ming University
Improvement of Mouth Breathing Habits During Sleep in Patients With Obstructive Sleep Apnea
This study intends to investigate the improvement in patients with OSA through objective measurement, including oxygen desaturation index (ODI) and the percentage reduction in intermittent mouth puffing (IMP) before and after the intervention.
The oral appliances are placed between the tongue and the soft palate to reduce the oral ventilation space.
A total of 24 participants aged between 36 and 57 years were identified with ODI above 5 events/hour by measuring their blood oxygen and with an originally designed mouth puffing detector to find out those who were still mouth-puffed when their mouths were taped.
A suitable appliance was chosen for the participants between the two originally designed oral appliances, tongue pressed device (TPD) and tongue elevated device (TED), and the intervention lasted for six weeks.
Study Overview
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- Faculty of Medicine, and Institute of Brain Science, National Yang-Ming Chiao-Tung University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- (1) aged 20-60 years old,
- (2) having symptoms of OSA including snoring, daytime sleepiness, etc.
- (3) AHI & ODI >=5 events/hour,
Exclusion Criteria:
- (1) taken sleep medication within the last two months or were on long-term use,
- (2) reported tobacco, alcohol, caffeine or drug addiction,
- (3) cancer, cardiovascular disease, psychiatric illness, kidney disease, diabetes mellitus, or other sleep disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
single arm study
|
A pre-experimental, single-group pretest-posttest design was performed.
At stage one, each participant underwent a 2-day general sleeping test and a 2-day sleeping test with mouth tape.
At stage two, participants underwent conventional impressions for TPD and TED appliances and were then randomly assigned to wear the TPD or TED; together for two days of sleeping test with their mouth taped.
After a 2-day break (washout), with the same procedure, participants wore the other appliance for another 2-day sleeping test and decided accordingly the optimal appliance that had reduced their ODI scores more.
At stage three, participants wore their optimal appliance mouth-taped during sleep for 6 weeks.
At the end of the intervention, all participants underwent few days sleeping test for final results.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in OSA-related variables before and after the six weeks oral device intervention
Time Frame: baseline, six weeks after intervention
|
According to OSA-related variables, we can analyze participants' ODI (events/hours), mean SpO2 (%), the lowest SpO2(%), and the percentage of total record time with oxygen saturation below 90% (T90) to evaluate their objective sleep quality.
|
baseline, six weeks after intervention
|
|
Differences in percentage of mouth puffing before and after the six weeks oral device intervention
Time Frame: baseline, six weeks after intervention
|
According to the number of mouth puffing by minutes, mouth puffing signals were divided into four types, including non-mouth puffing (NMP, no or less than 3 times MPSs on both sides), complete mouth puffing (CMP, regularly MPS on both sides, usually above 8-10 times), intermittent mouth puffing (IMP, irregularly MPS in both side, usually between 3-8 times), and side mouth puffing (SMP, showing one-side MPSs) to evaluate the percentage of mouth breathing while sleeping.
|
baseline, six weeks after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Cheryl CH Yang, professor, Institute of Brain Science ,National Yang-Ming University, Taipei City, Taiwan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 9, 2018
Primary Completion (Actual)
January 31, 2022
Study Completion (Actual)
January 31, 2022
Study Registration Dates
First Submitted
May 16, 2022
First Submitted That Met QC Criteria
June 1, 2022
First Posted (Actual)
June 3, 2022
Study Record Updates
Last Update Posted (Actual)
June 3, 2022
Last Update Submitted That Met QC Criteria
June 1, 2022
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YM107083E
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on OSA
-
Brigham and Women's HospitalRecruiting
-
Woolcock Institute of Medical ResearchFullpower Technologies, Inc.Recruiting
-
Brigham and Women's HospitalRecruiting
-
Biocubica srlCompleted
-
Mahidol UniversityUnknownOSA | ComplicationThailand
-
Chang Gung Memorial HospitalUnknown
-
Changi General HospitalCompleted
-
Atlantic Health SystemNot yet recruitingPrevalence of OSA in Patients Hospitalized With COPD Exacerbation
Clinical Trials on Oral Appliances
-
Mahidol UniversityUnknownOSA | ComplicationThailand
-
Cairo UniversitySuez UniversityNot yet recruiting
-
University of California, Los AngelesNational Institutes of Health (NIH)Active, not recruitingAutism Spectrum DisorderUnited States
-
Damascus UniversityCompletedCrowdingSyrian Arab Republic
-
Boston Children's HospitalCompletedDown SyndromeUnited States
-
University of California, Los AngelesNational Institutes of Health (NIH)CompletedAutism Spectrum DisorderUnited States
-
Al-Azhar UniversityCompleted
-
University of California, Los AngelesActive, not recruiting
-
Riyadh Elm UniversityNot yet recruitingSaliva | Orthodontic TreatmentSaudi Arabia
-
Mansoura UniversityActive, not recruitingSkeletal Class I Non-extraction Patients With Dental CrowdingEgypt